Review
Accepted on 30 Jun 2025
High-mobility group box 1 in acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1618971
Type at least 3 characters
660 articles
Original Research
Accepted on 30 Jun 2025
The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621208
Original Research
Accepted on 30 Jun 2025
Huangkui capsule combined with finerenone attenuate diabetic n ephropathy by regulating JAK2/STAT3 signaling pathway based on network pharmacology, molecular docking and experimental verification
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1625286
Original Research
Accepted on 30 Jun 2025
Acridocarpus smeathmannii Root Extracts Inhibit Human Prostate and Bladder Smooth Muscle Contraction, Porcine Arterial Vasoconstriction, and Cytotoxicity of Prostate Stromal Cells
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621346
Review
Published on 27 Jun 2025
Critical role of LncRNA in sepsis-associated acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627253
- 209 views
Systematic Review
Published on 24 Jun 2025
Effectiveness and safety of Shengxuening for treatment of renal anemia: a comprehensive systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510227
- 240 views
Original Research
Published on 24 Jun 2025
Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583515
- 251 views
Original Research
Published on 20 Jun 2025
Integrating single-cell RNA-seq, bulk RNA-seq and network pharmacology reveals protective effect of salidroside in peritoneal dialysis-associated peritoneal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558366
- 479 views
Original Research
Published on 20 Jun 2025
The impact of early use of statin in sepsis patients with acute kidney injury: a study based on MIMIC-IV
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1610450
- 447 views
Original Research
Published on 10 Jun 2025
Dimethyl malonate alleviates obstructive nephropathy by enhancing renal metabolism and inhibiting kidney oxidative stress and inflammation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1530635
- 635 views
Original Research
Published on 09 Jun 2025
Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551423
- 992 views
Systematic Review
Published on 02 Jun 2025
Tetramethylpyrazine and renal ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical studies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559314
- 783 views
Review
Published on 30 May 2025
Preexisting statin therapy is not associated with reduced acute kidney injury following cardiac surgery: a retrospective analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613681
- 910 views
Original Research
Published on 30 May 2025
ATP/P2X7 receptor/NLRP3 pathway facilitates renal tubular epithelial-myofibroblast transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598151
- 568 views
Original Research
Accepted on 27 May 2025
Luteolin delays the progression of IgA nephropathy by attenuating inflammation, oxidative stress and reducing extracellular matrix accumulation through activating the Nrf-2/HO-1 pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1530655
- 283 views
Original Research
Published on 27 May 2025
Xanthohumol ameliorates diabetic kidney disease through suppression of renal fibrosis by regulating SNHG10/miR-378b
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532517
- 820 views